Karas M, Huang D, Clement Z, et al. Smartphone Screen Time Characteristics in People With Suicidal Thoughts: Retrospective Observational Data Analysis Study. JMIR mHealth and uHealth. 2024;12:e57439. doi:10.2196/57439
Publications
van der Leun AM. Tertiary lymphoid structure formation: A matter of tumor-immune co-evolution. Molecular immunology. 2024;175:143-145. doi:10.1016/j.molimm.2024.09.012
Zhao BY, Hirayama S, Goss D, Zhao Y, Faden DL. Human papillomavirus-associated nasopharyngeal carcinoma: A systematic review and meta-analysis. Oral oncology. 2024;159:107057. doi:10.1016/j.oraloncology.2024.107057
You E, Danaher P, Lu C, et al. Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer. Cell. 2024. doi:10.1016/j.cell.2024.09.024
Haj AK, Ryu J, Jurgens SJ, et al. Loss of Function in Protein Z (PROZ) is Associated with Increased Risk of Ischemic Stroke in the UK Biobank. Journal of thrombosis and haemostasis : JTH. 2024. doi:10.1016/j.jtha.2024.09.016
Angelidi AM, Martinou EG, Karamanis DG. Metabolic-Bariatric Surgery Reduces Pancreatic Cancer Risk: A Meta-Analysis of Over 3.7 Million Adults, Independent of Type 2 Diabetes Status. Diabetes/metabolism research and reviews. 2024;40(7):e3844. doi:10.1002/dmrr.3844
Gutmann DH, Boehm JS, Karlsson EK, et al. Precision preclinical modeling to advance cancer treatment. Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae249
Tindi KBB, Kalungi A, Kinyanda E, et al. Psychological Distress Among Ethnically Diverse Participants From Eastern and Southern Africa. JAMA network open. 2024;7(10):e2438304. doi:10.1001/jamanetworkopen.2024.38304
Bergquist T, Stenton SL, Nadeau EAW, et al. Calibration of additional computational tools expands ClinGen recommendation options for variant classification with PP3/BP4 criteria. bioRxiv : the preprint server for biology. 2024. doi:10.1101/2024.09.17.611902
Frenking JH, Zhou X, Wagner V, et al. EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma. Journal for immunotherapy of cancer. 2024;12(10). doi:10.1136/jitc-2024-009220